These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 34484427)
1. Update on the management of overactive bladder. Fontaine C; Papworth E; Pascoe J; Hashim H Ther Adv Urol; 2021; 13():17562872211039034. PubMed ID: 34484427 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injections for adults with overactive bladder syndrome. Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study. Frey JN; Vidal A; Krebs J; Christmann C J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959248 [TBL] [Abstract][Full Text] [Related]
4. Surgical options for drug-refractory overactive bladder patients. Starkman JS; Smith CP; Staskin DR Rev Urol; 2010; 12(2-3):e97-e110. PubMed ID: 20811558 [TBL] [Abstract][Full Text] [Related]
6. Management of OAB in those over age 65. Natalin R; Lorenzetti F; Dambros M Curr Urol Rep; 2013 Oct; 14(5):379-85. PubMed ID: 23922134 [TBL] [Abstract][Full Text] [Related]
7. Evaluation and Treatment of Overactive Bladder in Women. Raju R; Linder BJ Mayo Clin Proc; 2020 Feb; 95(2):370-377. PubMed ID: 32029089 [TBL] [Abstract][Full Text] [Related]
8. Current management of refractory overactive bladder. Chen LC; Kuo HC Low Urin Tract Symptoms; 2020 May; 12(2):109-116. PubMed ID: 32073742 [TBL] [Abstract][Full Text] [Related]
12. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Rai BP; Cody JD; Alhasso A; Stewart L Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594 [TBL] [Abstract][Full Text] [Related]
13. [Management of overactive bladder in women]. Peyronnet B; Rigole H; Damphousse M; Manunta A Prog Urol; 2015 Nov; 25(14):877-83. PubMed ID: 26169251 [TBL] [Abstract][Full Text] [Related]
14. Augmentation enterocystoplasty in overactive bladder: is there still a role? Reyblat P; Ginsberg DA Curr Urol Rep; 2010 Nov; 11(6):432-9. PubMed ID: 20734172 [TBL] [Abstract][Full Text] [Related]
18. Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis. Balzarro M; Rubilotta E; Mancini V; Trabacchin N; Oppezzi L; Li Marzi V; Fusco F; Serati M Sex Med Rev; 2019 Oct; 7(4):565-574. PubMed ID: 31326358 [TBL] [Abstract][Full Text] [Related]
19. Overactive bladder--a practical approach to evaluation and management. Madersbacher H J Med Liban; 2004; 52(4):220-6. PubMed ID: 16432986 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Short Term Outcomes of Sacral Nerve Stimulation and Intradetrusor Injection of OnabotulinumtoxinA (Botox) in Women With Refractory Overactive Bladder. Singh R; El Nashar SA; Trabuco EC; Klingele CJ; Gebhart JB; Occhino JA Female Pelvic Med Reconstr Surg; 2015; 21(6):369-73. PubMed ID: 26506168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]